Leslie Fecher

5PUBLICATIONS
51CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 05, 2024
Outcomes With Postrecurrence Systemic Therapy Following Adjuvant Checkpoint Inhibitor Treatment for Resected Melanoma in CheckMate 238.

Jeffrey Weber, Michele Del Vecchio, Mario Mandalá

|May 25, 2023
A Brain, A Heart, and the Courage: Balancing Benefit and Toxicity of Immunotherapy in Melanoma.

Yen-Chou Chen, Muhammad Jaffer, Lylybell Zhou

|Apr 14, 2023
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238.

James Larkin, Michele Del Vecchio, Mario Mandalá

|Nov 01, 2021
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.

Bryan J Schneider, Jarushka Naidoo, Bianca D Santomasso

|Nov 01, 2021
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline.

Bianca D Santomasso, Loretta J Nastoupil, Sherry Adkins

Pageof 1

Frequent Collaborators

4 joint publications

Jeffrey Weber

2 joint publications

James Larkin

2 joint publications

Luis de la Cruz-Merino

2 joint publications

Mario Mandalá